1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
THE MANAGEMENT OF ANTICOAGULANT THERAPY DURING AND AFTER PREGNANCY
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1975.tb00715.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 82, Issue 9, pages 740–744, September 1975
Additional Information
How to Cite
Pridmore, B. R., Murray, K. H. and Mcallen, P. M. (1975), THE MANAGEMENT OF ANTICOAGULANT THERAPY DURING AND AFTER PREGNANCY. BJOG: An International Journal of Obstetrics & Gynaecology, 82: 740–744. doi: 10.1111/j.1471-0528.1975.tb00715.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
Fifteen patients were treated with oral anticoagulants during pregnancy. At 37 weeks they were changed to heparin and were given 5 mg of Vitamin K1 by intravenous injection. Labour was induced seven to ten days later. All infants were normal and healthy and in the 12 tested the cord prothrombin times were within the normal range.